Luca Alina-Costica, Curpan Alexandrina-Stefania, Miron Ingrith, Horhota Emma Oana, Iordache Alin-Constantin
Faculty of Medicine, "Grigore T. Popa", University of Medicine and Pharmacy, Strada Universitatii 16, 700115 Iasi, Romania.
Department of Biology, Faculty of Biology, "Alexandru Ioan Cuza" University of Iasi, Bd. Carol I, 20A, 700505 Iasi, Romania.
Medicina (Kaunas). 2020 Nov 5;56(11):588. doi: 10.3390/medicina56110588.
Wolff-Parkinson-White (WPW) syndrome is a rare abnormal condition frequently associated with paroxysmal supraventricular tachycardia (PSVT) and is described as an arrhythmia under the form of increased heartbeat. Currently, there are various possible treatments going from medicines such as adenosine and beta-blockers to cardioversion. The unknown causes of this condition together with the different responses to treatment in each patient make it difficult to establish the best therapeutic approach. In this context, in the current paper, we were interested in reporting the therapeutic options and their efficiency in the case of associated heart or inflammatory conditions in a 13-day-old patient.
预激综合征（WPW）是一种罕见的异常情况，常与阵发性室上性心动过速（PSVT）相关，被描述为心跳加快形式的心律失常。目前，有多种可能的治疗方法，从腺苷和β受体阻滞剂等药物到心脏复律。这种疾病的病因不明，加上每个患者对治疗的不同反应，使得难以确定最佳治疗方法。在此背景下，在当前论文中，我们感兴趣的是报告一名13天大患者合并心脏或炎症性疾病时的治疗选择及其疗效。
